Research

2019 ISN GKHA Survey Results on Worldwide Kidney Care Capacity Published in BMJ Open

The paper, “Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey,” has been published in BMJ Open. Read the paper here. The ISN GKHA is a worldwide survey to assess the current capacity for kidney care. Designed to document the availability of the six principles* of Universal Health Coverage...

ISN i3C Network: Watch a Series of Webinars on Kidney Biopsy, Explore Ongoing CKDu Research, and Share Your Data on the ISN Observatory of CKDu

From the ISN i3C (International Consortium CKDu Collaborators) network: A series of innovative digital activities to guide nephrologists and healthcare leaders on implementing a kidney biopsy program. The activities include webinars, educational videos, and two audio interviews on the ISN Academy. Access here. The ISN Observatory of CKDu facilitates data sharing and collaboration between the diverse...

Access Chapter Two of the ISN-ACT Clinical Trials Toolkit Narratives

To facilitate understanding of important clinical trial methodologies, the ISN-ACT Clinical Trials Toolkit subgroup members are producing a series of stories based on various ISN-ACT Clinical Trials Toolkit topics. The second of these narratives outlines several trial design methods through fictional clinical discussions. Access chapter two here. The ISN-ACT Clinical Trials Toolkit is a comprehensive step-by-step...

Paper on Kidney Biopsy Codes Published

BMC Nephrology has published a paper on coding practice in national and regional kidney biopsy registries. The paper gives an overview of kidney biopsy registries, explores how kidney diseases are coded, and demonstrates the need to improve coding practice. This is the first publication from the Kidney Biopsy Codes for pathologists project, which aims to provide...

Kidney International Reports Celebrates Five Years of Presenting Outstanding Research in Nephrology

The Kidney International Reports' (KIR) Jai Radhakrishnan, editor-in-chief, Sumit Mohan, deputy editor, and Radha McLean, executive editor, highlight the journal's significant role in disseminating valuable research in nephrology, having published over 1,000 articles since its launch in 2016. The article, 5 Years (And Counting) of Expanding Access to Kidney Disease Research, marking the fifth anniversary...

International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020 – Slide Deck and User Guide

In October 2020, Kidney International published the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020 developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, earlier that year. The paper has been summarized into a slide deck and user guide for...

ISN-H4KH Grant Awardee Has Research Results Published in KI Reports

In 2018, Amarasiri de Silva (Sri Lanka/USA) received an ISN-H4KH (Hydration for Kidney Health) Fellowship Grant. His abstract, "POS-314 People’s knowledge of Chronic Kidney Disease of Unknown Etiology in Sri Lanka," was accepted for presentation at WCN21 and published in Kidney International Reports. Amarasiri de Silva investigated a Sri Lankan population's knowledge of CKDu, and their...

Announcing the Updated ISN-ACT Clinical Trials Toolkit

An updated edition of the ISN-ACT Clinical Trials Toolkit is now available. It includes additional content and new resources. The Toolkit was updated and improved based on feedback from the ISN-ACT Toolkit subgroup and the nephrology community. The Toolkit is an ISN open-access, online resource to guide trial design, study conduct, data management, data analysis, and publications....

Final Webinar in the SGLT2i Series: Toward Equitable Access to Kidney Treatment

The ISN Webinar, Dissemination and Implementation of Therapies for Kidney Diseases in Low- and High-Income Countries, will be broadcast on Thursday, April 29, at 3 p.m. CEST (convert to your time zone here). Register here. SGLT2i inhibitors protect the heart and the kidney, but equitable access to these and other drugs for Chronic Kidney Disease and...